18 Members•4,119 Posts

Health

Leading bank backs European pharma as the cleaner alternative to the AI trade

Jul 8, 2026

Ian Lyall

OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain

Jul 8, 2026

Steve Darling

ResMed sharpens core focus with US$490 million MatrixCare sale

Jul 8, 2026

Jonathan Jackson

Proteomics International secures US patent for endometriosis blood test

Jul 8, 2026

Jonathan Jackson

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain

Jul 8, 2026

Emily Jarvie

4basebio appoints Cornel Chiriac as non-executive director

Jul 8, 2026

Ian Lyall

Futura to appeal European patent decision

Jul 7, 2026

Ian Lyall

AtaiBeckley set to unlock value from positive depression therapy trial results, says Jefferies

Jul 7, 2026

Emily Jarvie

Alterity Therapeutics clears key FDA hurdle for ATH434 Phase 3 pathway

Jul 7, 2026

Jonathan Jackson

Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort

Jul 7, 2026

Jonathan Jackson

OKYO Pharma announces participation in Piper Sandler 2026 Virtual Ophthalmology Symposium

Jul 7, 2026

Emily Jarvie

Coiled Therapeutics, IXICO, EnSilica, Capita - Small Cap Snapshot

Jul 7, 2026

Stephen Gunnion

Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion

Jul 7, 2026

Ian Lyall

IXICO lifts revenue forecast on contract wins and wider client base - UPDATE

Jul 7, 2026

Ian Lyall

Grey Matters receives first Brain PET scanner for flagship Florida Alzheimer's clinic

Jul 6, 2026

Steve Darling

Citi keeps AstraZeneca on 'buy' ahead of second-quarter results

Jul 6, 2026

Ian Lyall

Orthocell to discuss US rollout in coming webinar

Jul 6, 2026

Jonathan Jackson

Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic

Jul 6, 2026

Emily Jarvie

AtaiBeckley completes dosing in Phase 2b depression trial, expects topline data in Q4

Jul 6, 2026

Emily Jarvie

Futura Medical: new US Eroxon deal and positive WSD4000 women's health data

Jul 6, 2026

Stephen Gunnion

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy